stockportfolio.pro
Stocks / TECH vs UHS
TECH vs UHS
Bio-Techne Corporation and Universal Health Services, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Bio-Techne Corporation (TECH) | Universal Health Services, Inc. (UHS) | |
|---|---|---|
| Market cap | $8.8B | $8.8B |
| Revenue (latest FY) | $1.22B | $17.36B |
| Net income (latest FY) | $73.40M | $1.49B |
| Revenue growth (5y CAGR) | 10.5% | 8.5% |
| Net margin | 6.0% | 8.6% |
| Return on equity | 3.8% | 20.5% |
| P/E ratio | 80.2 | 6.1 |
| Dividend yield | 0.6% | 0.5% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open TECH — free Open UHS — freeFrequently asked questions
Which is bigger, TECH or UHS?
Universal Health Services, Inc. is larger by market capitalization — $8.8B versus $8.8B.
Which grows faster, TECH or UHS?
Over the last five fiscal years, Bio-Techne Corporation grew revenue faster — 10.5%/yr versus 8.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.